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EuropeIn recent years various EU/EEA countries have experienced an influx of migrants from low and middle-
income countries. In 2018, the ‘‘Vaccine European New Integrated Collaboration Effort (VENICE)” survey
group conducted a survey among 30 EU/EEA countries to investigate immunisation policies and practices
targeting irregular migrants, refugees and asylum seekers (later called ‘‘migrants” in this report). Twenty-
nine countries participated in the survey. Twenty-eight countries reported having national policies tar-
geting children/adolescent and adult migrants, however vaccinations offered to adult migrants are lim-
ited to specific conditions in seven countries. All the vaccinations included in the National
Immunisation Programme (NIP) are offered to children/adolescents in 27/28 countries and to adults in
13/28 countries. In the 15 countries offering only certain vaccinations to adults, priority is given to
diphtheria-tetanus, measles-mumps-rubella and polio vaccinations. Information about the vaccines
given to child/adolescent migrants is recorded in 22 countries and to adult migrants in 19 countries with
a large variation in recording methods found across countries. Individual and aggregated data are report-
edly not shared with other centres/institutions in 13 and 15 countries, respectively. Twenty countries
reported not collecting data on vaccination uptake among migrants; only three countries have these data
at the national level. Procedures to guarantee migrants’ access to vaccinations at the community level are
available in 13 countries. In conclusion, although diversified, strategies for migrant vaccination are in
place in all countries except for one, and the strategies are generally in line with international recommen-
dations. Efforts are needed to strengthen partnerships and implement initiatives across countries of, France;
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5440 C. Giambi et al. / Vaccine 37 (2019) 5439–5451origin, transit and destination to develop and better share documentation in order to guarantee a com-
pletion of vaccination series and to avoid unnecessary re-vaccination. Development of migrant-friendly
strategies to facilitate migrants’ access to vaccination and collection of vaccination uptake data among
migrants is needed to meet existing gaps.
 2019 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years European Union/European Economic Area
(EU/EEA) countries have experienced an influx of refugees and
other migrants [1] from low and middle-income countries. In
2017 more than 186,000 migrants arrived in Europe [2] and the
estimates for 2018 show more than 144,000 new arrivals [3].
Although the trend is declining compared to 2016 (390,432 arri-
vals) [3], the numbers are still very high.
Migrants can be exposed to malnutrition, unsanitary conditions,
displacement, among many other factors, which can make them a
vulnerable group with an increased risk for acquiring communica-
ble diseases. Moreover, overcrowding of holding/detention centres
or refugee camps favour the spread of communicable diseases
[4–10]. Also, unstable conditions in many migrants’ countries of
origin may have led to the disruption of national healthcare ser-
vices, including immunisation programmes which has led to falls
in vaccination coverage. For example, in Syria, the country of origin
of the largest number of asylum seekers in the EU since 2013 [11],
immunisation coverage for three doses of diphtheria-tetanus-
pertussis and polio has greatly decreased, from 75 and 60%, respec-
tively, in 2011 to around 50% in 2017. [12]. Concurrently, vaccine
hesitancy has become a significant public health issue in several
European countries and this is leading to increasing difficulties in
maintaining adequate vaccination rates in the general population
[13–15]. Geographical clusters with high proportions of unvacci-
nated people can lead to large VPDs outbreaks in host countries,
even though the rest of the population is well protected with ade-
quate vaccination coverage [16,17]. In 2018, 12,352 cases and 36
deaths due to measles have been reported in the EU [18] similar
to 2017 when over 14,000 people contracted measles and 30 peo-
ple died [19]. In the past two years, two people have died from
diphtheria in the EU [20] and an outbreak of vaccine-derived polio-
virus in Ukraine in September 2015 revealed that the risk of polio-
virus reintroduction in the EU still persists [21,22]. The rapid influx
of large numbers of potentially unvaccinated people could increase
existing immunity gaps, as was shown by a number of outbreaks of
VPDs in migrant settings described in Europe in the last years
[6–10], some of which were due to contacts with the general
population [7].
In November 2015, WHO-UNHCR-UNICEF advocated for the
right and the need to include the provision of vaccines in public
health interventions that target refugees, asylum-seekers and
migrants and provided general principles to guide this process
[21]. In 2015 and 2018 the European Centre for Disease Prevention
and Control (ECDC) developed technical documents that provide
scientific advice around on vaccination of migrants [23,24]. There
is a general agreement on the need to assess vaccination status
for all migrants using the available documentation, such as immu-
nisation cards, and offering supplementary vaccinations to those
unprotected, according to the national immunisation guidelines
of the country that they have arrived in. However, migrants gener-
ally do not have a record of their immunisation status as individual
immunisation cards are often lost during the long journey.
Furthermore, since immunisation is a health intervention requiringa continuum of follow-up until the full schedule is complete, coop-
eration among the health authorities of countries of arrival, transit
and destination is required.
Knowledge and sharing of immunisation strategies targeting
migrants in host countries could represent a starting point to facil-
itate cooperation among the different countries. Data on strategies
for migrant immunisation that are in place in EU countries is cur-
rently limited [25–27].
In 2017, in the framework of the EU-funded project ‘‘CARE:
Common Approach for REfugees and other migrants’ health”
(www.careformigrants.eu), a survey that looked at immunisation
policies targeting irregular migrants, refugees and asylum seekers
in six European countries participating in the project (Croatia,
Greece, Italy, Malta, Portugal and Slovenia) revealed differences
in immunisations policies across countries [25].
In 2018, in order to have a broader picture of these policies, an
extended survey was provided to all EU/EEA countries within the
ECDC-funded project ‘‘Vaccine European New Integrated Collabo-
ration Effort (VENICE)” (http://venice.cineca.org/). The aim of this
survey was to map out immunisation policies targeting irregular
migrants, refugees and asylum seekers in EU/EEA countries and
to explore practices and procedures put in place to respond to their
vaccination needs.2. Methods
The survey, coordinated by the Italian National Institute of
Health (Istituto Superiore di Sanità) in collaboration with ECDC,
was conducted among the 28 EU and two EEA countries (Iceland,
Norway) between the period January-April 2018.
Data were collected through an online questionnaire, developed
using Survey Monkey (www.surveymonkey.com). The question-
naire, based on the survey designed for the CARE project, consisted
of 79 closed-ended questions, with optional space for input of free
text. The following topics were surveyed: (i) existence of regula-
tions supporting vaccinations offered to migrants; (ii) immunisa-
tion strategies targeting child/adolescent and adult migrants, in
terms of vaccinations offered; target groups for vaccination; check
of immunisation status for VPDs; sites of vaccination delivery;
(iii) recording and transmission of information on delivered vacci-
nes; (iv) practices and challenges, including availability of proce-
dures to guarantee migrant access to vaccination; immunisation
Standard Operative Procedures (SOPs); data on immunisation
uptake among migrant populations and their compliance with vac-
cination recommendations.
The site of vaccination delivery was defined as: (i) entry level,
i.e. vaccination at the border/point of entry into the country (e.g.,
harbours or airports), (ii) holding level, i.e. vaccination provided
in migrant centres/camps, (iii) community level, i.e. vaccination
provided after arrival and partial integration into the community
in the receiving country, through the same services used by the
general population (e.g. in the primary health care centres or vac-
cination services) or through health services dedicated to migrants.
The survey was piloted in two EU countries (Germany and
Sweden) during the period of November 2016-April 2017 and
Table 1
National/regional regulation or legal framework supporting immunisation of
migrants (n = 28).
National legal framework/
regulation
Country Tot. %*
No national legal framework/
regulation
EE, IE, LU, MT 4 14.3
Part of National
Immunization Programme
(NIP)
AT, BG, CY, DE, DK*, FI, FR, HU,
IS, IT, LT, LV, NO, PL, PT, SE**,
SK**, UK
18 64.2
Specifically established for
migrants’ immunization
BE, EL, HR, IT, SI 5 17.9
Specifically dedicated to
migrant health services
DE, FI, NL 3 10.7
Other ES^ 1 3.5
Regional (or other
intermediate level) legal
framework/regulation
No regional legal framework/
regulation
BG, CY, DK, EE, EL, FI, FR, HR,
HU, IE, IS, IT, LT, LU, LV, MT, NL,
NO, PT, SE, SI, SK, UK
23 82.1
Yes, IN ALL REGIONS (or other
intermediate level) it is
part of the regional
regulation/legal
framework for
vaccinations
BE 1 3.5
Yes, ALL REGIONS (or other
intermediate level)
established a regulation/
legal framework
specifically for migrants’
BE, PL 2 7.1
C. Giambi et al. / Vaccine 37 (2019) 5439–5451 5441modified accordingly. As the CARE survey was completed by
Southern European countries of migration arrival (e.g. Greece, Italy
and Malta) or transit (e.g. Croatia and Slovenia), we decided to pilot
the new survey in two Northern European ‘‘destination countries”
with a high migratory flow. Moreover, both Germany and Sweden
have decentralized health systems so it was important to ensure
that the questions were appropriate also for countries with sub-
national variability.
The survey was provided to the ECDC National Focal Points for
VPDs (nominated by the National Coordinator and with a specific
role of coordination for vaccine preventable diseases within the
country and in the relation with ECDC) from the 30 EU/EEA coun-
tries currently participating in the VENICE project; they were asked
to complete the questionnaire involving, if needed, other experts in
migration health or to identify experts with knowledge of vaccina-
tion and migration for completing it. In order to ensure consistency
in the use of key migration-related definitions, we suggested
experts to refer to the International Organization for Migration
(IOM) glossary of terms [1], which is thus the reference for this
study. We carried out a descriptive analysis of survey responses
using absolute frequencies with percentages for all the categorical
variables collected and used the free-text responses to better
understand details of national situations (without performing
any qualitative data analysis).
The experts were asked to validate their answers after data
analysis, after the production of the final report and when review-
ing the article manuscript.immunization
Yes, SOME REGIONS (or other
intermediate level)
established a regulation/
legal framework
specifically for migrants’
immunization
AT 1 3.5
Yes, SOME REGIONS (or other
intermediate level)
established a regulation/
legal framework for all
health services specifically
dedicated to migrants
DE, ES, FI 3 10.7
The sum of percentage exceeds 100% because some countries have chosen more
than one option.
* DK: only children and adolescent are covered.
** SE, SK: only children are covered.
^ ES: children and adolescents are entitled to the same recommendations as3. Results
Among the 30 EU/EEA countries, 29 countries participated in
the survey (i.e. the response rate was 96.7%). There was no
response from the Czech Republic as all migration issues are under
the direction and coordination of the Ministry of Interior. Among
the 29 participating countries, the focal point for VPDs for Romania
stated that immunization policies targeting migrants were not in
place at the time of the survey; neither a national regulation/legal
framework, nor other non-legally-binding national documents
(such as technical guidance, guidelines or recommendations) sup-
porting immunization of migrants were available in the country.
Consequently, the following results refer to the 28 countries with
migrant immunization strategies in place at the time of the survey.general population; for adults a national regulation provide health assistance in
special situations. Spanish Ministry of Health is working on a guideline about
migrants which has a specific section for vaccination and accelerated immunization
program.3.1. National/regional regulation supporting immunisation of migrants
Twenty-four out of 28 (85.7%) countries reported having a
national regulation or a legal framework supporting immunisation
of migrants and four countries reported that they do not have one
(EE, IE, LU, MT) (Table 1). In 18 countries (64.3%) the regulation/
legal framework is part of the National Immunisation Programme
(NIP); in five countries (17.9%) a national regulation/legal frame-
work was specifically established for migrants’ immunisation (BE,
EL, HR, SI) or for all migrant health services (NL); in Spain, migrant
children and adolescents are covered by the same recommenda-
tions as the general population, while for migrant adults there is
a national regulation in place that outlines provision of health
assistance in emergency situations, such as a large influx of
migrants. In three countries (DE, FI, IT), although vaccination
strategies are included in the NIP, a regulation specifically dedi-
cated to migrants has also been established. A regional regulation
supporting migrant immunisation is available in six countries
(21.4%) (Table 1).
Most countries (22, 78.6%) stated that immunisation practices
targeting migrants are homogeneous in the whole country. Six
countries (AT, BE, DE, FI, IT, SE) reported that immunisation prac-tices vary regionally. Among these countries, the responder for
Belgium reported that there are regional differences in the routine
immunisation programme for adults (Flemish community: adult
vaccinations are based on the lifetime immunization schedule;
French speaking community: diphtheria-tetanus-pertussis vacci-
nation if offered only to pregnant women). Finland specified that
the national legal framework supports immunisation of all
migrants apart from irregular migrants, however the capital city
Helsinki has a regulation that enables irregular migrants to access
public health services, including vaccinations. Italy reported that
immunisation policies targeting migrants should be homogeneous
in the whole country as it is based on national law. However, due
to the decentralised health system and the fact that some regions
are more heavily affected by migration than others, in some
local/regional areas further additional vaccines are offered to
migrants in addition to those included in the national scheme.
At the time of the survey, other non-legally-binding national
documents such as technical guidance, guidelines or recommenda-
tions that support vaccination offered to migrants were available
5442 C. Giambi et al. / Vaccine 37 (2019) 5439–5451in all 28 countries except seven (BG, CY, FR, HR, HU, LU, LV). France
is planning to put in place specific guidelines for vaccinations
offered to migrants in 2019.
3.2. Child and adolescent migrants: Immunisation policies
All 28 countries have policies in place for offering vaccinations
to migrant children/adolescents (Fig. 1), however there are differ-
ences between the countries. Although Luxembourg has no legal
framework/regulation nor any non-legally binding national docu-
ment in place, the responder for this country specified that they
follow national recommendations for immunisation that target
the general population including migrants.
Asylum seekers are offered vaccinations in all countries; details
for target groups by migrant status and age are reported in Table 2.
In six countries (21.4%), national strategies include specific indi-
cations targeting people coming from specific countries of origin:
- Belgium: Inactivated Polio Vaccine (IPV) for adolescents coming
from countries with potential risk for international spread,
while for children IPV is offered to all because it is included in
the NIP.
- Finland: Bacillus Calmette–Guérin (BCG) vaccine for children
under seven years of age coming from countries with a tubercu-
losis incidence  50/100,000 in the general population; hepati-
tis B vaccine for new-borns with a parent who originates from a
country with prevalence  5% of HBsAg.
- Ireland: IPV for refugees from Syria.Fig. 1. Immunisations offered to child/adolescent an- Norway: BCG vaccine for people coming from high risk coun-
tries; Hepatitis B vaccine for people coming from non-low inci-
dence countries.
- The Netherlands: BCG vaccine for children up to 12 years of age
coming from endemic areas.
- Slovakia: BCG vaccine for children coming from endemic areas,
regardless of age.
Migrant children and adolescents are offered all the vaccina-
tions included in the NIP appropriate for age in all countries but
Slovakia. In Slovakia asylum seekers are offered IPV and measles
vaccines after their arrival; furthermore, since the 2015 large
migration influx, illegal migrants are offered the following vacci-
nes: diphtheria-tetanus-pertussis (DTP), IPV, Haemophilus influen-
zae type b (Hib), Hepatitis B, Measles-Mumps-Rubella (MMR),
pneumococcal conjugate vaccine (PCV), BCG, as well as influenza
vaccination for children belonging to high-risk groups.
Twelve countries (42.9%) (DK, EE, ES, FI, FR, IS, LT, LU, LV, NL,
NO, SI) reported that there is no specific vaccination that is consid-
ered a priority compared to others. Among the other 16 countries,
high priority is given to polio vaccine (15 countries) and MMR vac-
cine (14 countries), followed by diphtheria-tetanus (DT) vaccine
(11 countries).
3.3. Child and adolescent migrants: Immunisation practices
All 28 countries reported that migrant children and adolescents’
immunisation status is checked verbally or by looking throughd adult migrants in EU/EEA countries (N = 29).
Table 2
Immunisations offered to child/adolescent migrants in EU/EEA countries: target
groups and vaccinations offered (N = 28).
Countries n %*
Target group by migrant
status
Unaccompanied minors AT, BE, BG, CY, DE, DK, EL, ES, FI,
FR, HR, HU, IE, IS, IT, LT, LU, LV,
MT, NL, NO, PL, PT, SE, SK, UK
26 92.9
Irregular migrants AT, BE, BG, CY, DE, DK#,EL, ES, FR,
HU, IE, IS, IT, LT, LU, MT, NL, NO,
PL, PT, SE, UK
22 78.6
Asylum seekers AT, BE, BG, CY, DE, DK, EE, EL, ES,
FI##, FR, HR, HU, IE, IS, IT, LT, LU,
LV, MT, NL, NO, PL, PT, SE, SI, SK,
UK
28 100.0
Refugees AT, BE, BG, CY, DE, DK, EE, EL, ES,
FI##, FR, HR###, HU, IE, IS, IT, LT,
LU, LV, MT, NL, NO, PL, PT, SE, SI,
SK####, UK
28 100.0
Age limit for vaccination
offer
18 years BE, BG, CY, DE, DK, EE, ES, FI, FR,
HR, IE, IS, IT, LT, LV, NL, PT, SE, SI,
SK, UK
21 75.0
Other age limit (years
specified in brackets)
AT (15), EL (15), HU (20), LU (15),
MT (17), NO (16), PL (19)
7 25.0
Childhood vaccinations
offered to migrants
All the vaccinations
included in the
National Immunisation
Plan
AT, BE, BG, CY, DE, DK, EE, EL^, ES,
FI, FR, HR, HU, IE, IS, IT, LT, LU, LV,
MT, NL, NO, PL, PT, SE, SI, UK,
27 96.4
Only certain vaccinations
are offered to migrants
SK 1 3.6
# DK: irregular migrants have the right to medical care in case of emergency,
including immunisation.
## FI: vaccinations are offered to all migrants with a residency permit and a citi-
zenship, and particular attention is focused on refugee and asylum seeking; irreg-
ular migrants are not offered vaccination with the exception of some cities and
municipalities.
### HR: refugees who are transiting the country, including irregular migrant, are
not offered vaccinations; Immigrants such as those with granted asylum or inter-
national protection are eligible for the vaccination free of charge according to
national immunization programme.
#### SK: the vaccination is legally supported for children/adolescent of asylum
seekers or unaccompanied children. Illegal migrants are not offered vaccinations,
although since the huge migrant influx of 2015 a recommendation has been issued
for this group. If a child is given the asylum it should be vaccinated according to our
vaccination schedule as the general population.
 UK: vaccinations are offered to all migrants; the status check and immunisation
offer is made when they attend a primary care service. The age limit depends on the
specific vaccination and doses received as for the NIP (e.g. Men ACYW135 may be
offered up to 25th birthday).
^ EL: the NIP vaccines are given to migrant children in routine primary care
services after they have settled in the community, while in campaigns and camps
the policy is to carry out the following priority vaccines: DTP, IPV, Hib, Hepatitis B,
MMR, PCV, BCG, as well as influenza vaccination for high-risk groups.
C. Giambi et al. / Vaccine 37 (2019) 5439–5451 5443records/immunisation cards, when these are available. In case of
unknown or uncertain immunisation status, laboratory evidence
of immunity is requested in three countries (DK, IE, IT), mainly
for hepatitis B, diphtheria and tetanus (Table 3).
Vaccination schemes specifically adapted to migrant children
and adolescents’ (in addition to those applied to the general popu-
lation) are adopted in two countries (IE, NL) (Table 3).
Vaccinations are mainly delivered at holding (21/28, 75%) and
community (27/28, 96.4%) level. Migrants are immunised at entry
level in five countries. Informed consent is requested from migrant
parents/guardians in 25 countries (89.3%), mainly verbally.
Twenty-six countries offer vaccinations free of charge to all
migrant children/adolescents, except for Ireland and Norway
where there is a cost for some vaccinations (Table 3).3.4. Adult migrants: Immunisation policies
All 28 countries reported that vaccinations are offered to adult
migrants; however, 7 countries (25%) (DK, ES, HU, HR, NL, SI, SK)
limit the vaccinations offered based on certain conditions (Fig. 1).
The respondents of these countries have provided the following
details:
- Croatia: asylum seekers aged 18–35 years;
- Denmark and the Netherlands: same risk groups as for the gen-
eral population;
- Slovenia and Hungary: if there is an epidemiological or clinical
indication (e.g. post-exposure prophylaxis for tetanus or in case
of outbreaks);
- Slovakia: there is no legislative support for vaccination policy
for adult asylum seekers and refugees; however, appropriate
vaccinations are offered on the basis of the medical examina-
tion, especially against Hepatitis B (after serological test) and
BCG vaccine for migrants from risk countries;
- Spain: all pregnant women and adult migrants only in emer-
gency situations (i.e. in case of an outbreak).
Asylum seekers are offered vaccinations in all countries; details
for target groups by migrant status and age are reported in Table 4.
There is no specific age cut-off limit for which vaccinations are
offered to adults in all countries except for Croatia. In Croatia pri-
ority is given to people under 35 years of age; however, migrants of
older age are eligible for free-of-charge vaccination if there is an
epidemiological indication (e.g. in case of an outbreak). A new reg-
ulation supporting migrant immunisation has been proposed in
Croatia, according to which this cut-off age limit will be removed.
In seven countries (25%), national strategies include specific
indications targeting migrants arriving from specific countries of
origin. IPV vaccine is offered to migrants coming from endemic
countries or countries at risk of reintroduction in Belgium, Cyprus,
Hungary (migrants from Pakistan and Afghanistan), Ireland (asy-
lum seekers and refugees from Syria) and Italy. BCG vaccine is
offered in Norway to migrants under 35 years of age coming from
high risk countries and Slovakia. Hepatitis B vaccine is offered to
migrants coming from non-low incidence countries in Norway.
Thirteen countries (46.4%) reported that adult migrants receive
all the vaccinations included in the NIP appropriate for age and 15
only offer certain vaccinations to adult migrants (Table 4). Slovenia
did not specify which vaccines are offered, stating that adult
migrants are only vaccinated in case of epidemiological indications
(e.g. hepatitis A in case of outbreak) (Fig. 2). The respondent for
Italy specified that IPV and MMR vaccines are offered to adult
migrants as a priority, but they are offered all the vaccinations
included in the NIP if they are permanent residents in the country.
In Finland, vaccinations offered to migrant adults are dependent
upon their immigration status: resident migrants and refugees
are offered all vaccinations included in the NIP, whereas asylum
seekers are offered only certain vaccinations (dT, MMR, IPV and,
if living in a reception centre, influenza vaccine).
Ten out of 28 countries (35.7%) (BG, DK, EE, IS, LT, LU, LV, NL, SI,
SK) reported that no vaccination is considered a priority compared
to others; among the other 18 countries, high priority is given to
IPV vaccine (17 countries), followed byMMR vaccine (14), diphthe-
ria (11) and tetanus (10) vaccines.3.5. Adult migrants: Immunisation practices
In case of unknown or uncertain immunisation status, labora-
tory evidence of immunity is requested in four countries, mainly
for hepatitis B (Table 5).
Table 3
Immunisations offered to child/adolescent migrants in EU/EEA countries: vaccination practices (N = 28).
Countries n %
Use of laboratory evidence of immunity in case of unknown or uncertain immunisation status
Not requested AT, BE, BG, CY, DE, EE, EL, ES, FI, FR, HR, HU, IS, LT, LU, MT, LV, NL, NO, PL, PT, SE, SI, SK,
UK
25 89.3
Requested only for certain VPDs or specific conditions^ DK, IE, IT 3 10.7
Details on vaccination scheme
Identical to that applied to the general population AT, BE, BG, CY, DE, DK, EE, EL, ES, FI, FR, HR, HU, IS, IT, LT, LU, LV, MT, NO, PL, PT, SE, SI,
SK, UK
26 92.9
Vaccination scheme specific for migrants^^ IE, NL 2 7.1
Sites for vaccination delivery
At entry level AT, BE, CY, PL, UK 5 17.9
At holding level AT, BE, BG, CY, DE, DK, EL, FI, HR, HU, IE, IS, IT, LT, LU, MT, NL, NO, PL, SK, UK 21 75.0
At community level through the same services used by general
population
AT, BE, BG, CY, DE, DK, EE, EL, ES, FI, FR, HR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PT, SE,
SI, UK
26 92.9
At community level, through health services dedicated to migrants DE, EL, FI, IE, PL, UK 6 21.4
Informed consent before vaccinating
Not requested EE, HU, IS 3 10.7
Written consent AT, IE, IT, LT, LU, PL, SK 7 25.0
Verbal consent BG, CY, DK, EL, ES, FI, FR, HR, LV, MT, NL, NO, PT, SE, SI, UK 16 57.1
Other^^^ BE, DE 2 7.1
Payment
Vaccinations offered free of charge AT, BE, BG, CY, DE, DK, EE, EL, ES, FI, FR*, HR, HU, IS, IT, LT, LU, LV, MT, NL, PL, PT, SE, SI,
SK, UK
26 92.9
Migrants have to pay for some of the vaccinations IE**, NO*** 2 7.1
 FR: National guidelines for vaccination of persons with unknown or uncertain status (including migrants) are expected in 2019.
^ DK: in case of uncertain immunisation status, one dose of diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine or diphtheria,
tetanus, pertussis, polio (dTaP-IPV) vaccine according to age (under or above 10 years of age) is offered and antibody level for diphtheria and tetanus is checked after a month;
IE: laboratory evidence of immunity for hepatitis B in case of people coming from high endemic countries, IT: laboratory evidence of immunity for hepatitis B and tetanus.
^^ IE: BCG vaccine provided to those up to 15 years of age if low risk, up to 35 years if high risk; Meningococcus C vaccine up to 23 years of age; twoMMR vaccine doses 1 month
apart from age 4 years; three dTap/IPV vaccine doses 1 month apart for ages 10–17 years and one dTap/IPV vaccine dose followed by two dT/IPV vaccine doses 1 month apart for
migrants 18 years; NL: asylum seekers get an additional MMR vaccine dose at 9 months of age (the first MMR dose is offered at 14 months according to the NIP).
^^^ BE: Written consent except for entry point where verbal consent is asked. DE: Written or verbal consent depending on the locality.
* FR: vaccinations are free of charge for most of the migrants as the French citizens, with modalities of reimbursement depending on administrative status (French citizen
and regular migrants: 65% covered by the national health insurance, and 35% by private complementary insurance or complementary state insurance according to the income
– undocumented migrants: 100% covered by the state medical assistance for mandatory vaccinations). Additionally, vaccination can be performed free of charge in public
vaccination clinics.
** IE: vaccines are provided free of charge to children < 12 years. Adolescents get free vaccines within the school vaccination programme (menC, dTap, HPV-girls only);
administration charges normally apply to adolescents for other vaccines. Vaccines are offered free of charge (both vaccine and administration) to refugees and asylum
seekers. For irregular migrants, access to free vaccines is available, but costs for administration may be applied (unless provided by NGO service), except for young children
who are enrolled in the national childhood programme.
*** NO: all vaccines are offered free of charge to children in primary and secondary school; older adolescents have to pay for some vaccines.
Table 4
Immunisations offered to adult migrants in EU/EEA countries: target groups and vaccinations offered (N = 28).
Countries n %*
Target group: migrant status
Irregular migrants BE, BG, CY, DE, DK#, EL, ES, FR, HU, IE, IS, IT, LT, LU, MT, NL, NO, PL, PT, UK 20 71.4
Asylum seekers AT, BE, BG, CY, DE, DK, EE, EL, ES, FI##, FR, HR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PL, PT, SE, SI,
SK, UK
28 100.0
Refugees AT, BE, BG, CY, DE, DK, EE, EL, ES, FI##, FR, HR###, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PL, PT, SE,
SI, UK
27 96.4
Age limit for vaccinations offered
All ages AT, BE, BG, CY, DE, DK, EE, EL, ES, FI, FR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PL, PT, SE, SI, SK,
UK
27 96.4
Other age limit (35 years) HR^ 1 3.6
Vaccinations offered to adult migrants
All the vaccinations included in the National
Immunisation Plan
BE, BG, CY, DE, FI ##, FR, IE, LT, LU, NO, PT, SE, UK 13 46.4
Only certain vaccinations are offered to migrants AT, DK, EE, EL, ES, HR, HU, IS, IT, LV, MT, NL, PL, SI, SK 15 53.6
# DK: irregular migrants have the right to medical care in case of emergency, including immunisation.
## FI: vaccinations are offered to all migrants with a residency permit and a citizenship, and particular attention is focused on refugee and asylum seeking; irregular migrants
are not offered vaccination with the exception of some cities and municipalities. As regard to adult migrants, vaccination offer depends upon the immigration status: resident
migrants and refugees are offered vaccinations included in the NIP; asylum seeker adults are only offered certain vaccinations.
### HR: refugees who are transiting the country, including irregular migrant, are not offered vaccinations; according to the existing regulation, vaccination priorities are given
to immigrants such as those with granted asylum or international protection under 35 years of age, but migrants of older age are eligible for free-of-charge vaccination if
there is an epidemiological indication for vaccination. A new regulation supporting migrant immunisation is going to be approved, according to which this limit age will be
removed.
^ HR: vaccination priorities are given to children and younger adults (<35 years of age), but migrants of older age are eligible for free-of-charge vaccination if there is an
epidemiological indication for vaccination. A new regulation supporting migrant immunisation has been proposed, according to which this limit age will be removed.
 IT: polio and MMR vaccines are offered to adult migrants as a priority, but they are offered all the vaccinations included in the NIP if migrants are permanent resident in the
country.
 SI: in case of epidemiological indications, e.g. in case of outbreak.
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Fig. 2. Selective vaccinations offered to susceptible adult migrants or with undocumented immunisation status (n = 14). Countries offering each specific vaccine are
reported in the bar. Vaccinations offered: BCG (Bacillus Calmette–Guérin tuberculosis vaccine); HPV (human papilloma virus vaccine); PCV (pneumococcal conjugate
vaccine); Hib (Haemophilus influenzae type b); Men (meningococcal vaccine); HBV (hepatitis B vaccine), IPV (inactivated polio vaccine); MMR (measles-mumps-rubella
vaccine); dT/dTP (diphtheria-tetanus/ diphtheria-tetanus-pertussis).. AT: meningococcal C containing vaccine. EL: meningococcal vaccine in case of outbreak (ACYW135
quadrivalent vaccine or monovalent vaccine according to the serogroup of meningococcus responsible for the outbreak); influenza vaccine to risk groups.IS: meningococcal
C conjugate vaccine. ^DK: one MMR dose to all susceptible adults; the other vaccines offered to risk groups (MMR to susceptible women in childbearing age, hepatitis B
vaccine in case of close contacts of patients affected by chronic hepatitis B, dT in case of injury, influenza vaccination in case of underlining chronic conditions). *IT: tetanus
offered in case of exposed wounds. **HR: in case of epidemiological indication (i.e. close contacts with HBsAg positive persons).
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those applied to the general population, are adopted only in three
(IE, FI, MT) out of 27 countries (11.1%) (there was no response from
Cyprus for this question) (Table 5).
Vaccinations are mainly delivered at holding (19/28, 67.9%) and
community level (27/28, 96.4%); migrants are immunised at entry
level in five countries. Informed consent is requested from
migrants in 27 countries, mainly verbally. Twenty-one countries
(75%) offer vaccinations free-of-charge to adult migrants; in seven
countries (25%), adult migrants have to pay for some of the vacci-
nations (Table 5).3.6. Information on immunised migrants: Data collection, recording
and reporting
An individual vaccination card is given to migrants in most
countries (Table 6). Information on delivered vaccines is recorded
for children/adolescents in 22/28 countries (78.6%) and for adult
migrants in 19/28 countries (67.9%). Methods for recording infor-
mation differ greatly between countries (Table 6). The respondent
from Slovakia specified that there is no routine surveillance of vac-
cine coverage in migrants; however, within the administrative sur-
vey performed once a year the regional public health authorities
check the number of migrants vaccinated in their region. The
respondent for Germany specified that procedures vary across cen-
tres/regions and that only the number of administered vaccines is
collected by the Regional Health Authorities. In 13/28 countries
(46.4%) individual data are not made available or transmitted from
the sites where vaccinations are delivered to any other centre/
institution and in 15/28 countries (53.6%) aggregated data are also
not made available (Table 7).Data on migrants’ compliance with vaccination or immunisa-
tion coverage are not collected in 20 countries (71.4%). Only NL,
LU, PL collect this data at the national level (Table 6).3.7. Procedures and experiences to facilitate migrants’ access to
vaccination
Fourteen countries (50%) (BE, EE, FI, FR, HR, IE, IS, IT, LU, MT, NL,
NO, PT, UK) have procedures (e.g. outlining dedicated staff, system-
atic flow of information or formal agreement) to ensure migrants’
access to vaccinations at the community level (e.g. vaccination ser-
vices/health workers/GPs/paediatricians) if vaccinations are not
previously delivered at holding level. Procedures differ across
countries and in some countries these may only apply to specific
areas or target groups. Eight countries described their experience
(Table 8).3.8. Vaccine shortage
Among the overall 29 responding countries (including Roma-
nia), eighteen countries (62.1%) have experienced vaccine shortage
in the past two years, with the different vaccines and during differ-
ent time periods. However, no country reported that the shortage
was due to provision of vaccinations to migrants.4. Discussion
This paper provides the results from a survey of existing
national immunisation policies and practices targeting migrants
in 29 EU/EEA countries.
Table 5
Immunisations offered to adult migrants in EU/EEA countries: vaccination practices (N = 28).
Countries n %
Use of laboratory evidence of immunity in case of unknown or uncertain immunisation status
Not requested AT, BE, BG, CY, DE, DK, EE, EL, FI, FR#, HR, HU, IS, LT, LU, LV, MT, NL, NO, PL, PT, SE, SI,
UK
24 85.7
Requested only for certain VPDs or specific conditions## ES, IE, IT, SK 4 14.3
Details on vaccination scheme
Identical to that applied to the general population AT, BE, BG, DE, DK, EE, EL, ES, FR, HR, HUIS, IT, LT, LU, LV, NL, NO, PL, PT, SE, SI, SK, UK 24 85.7
Vaccination scheme specific for migrants* FI, IE, MT 3 10.7
Not reported this information CY 1 3.6
Sites for vaccination delivery
At entry level AT, BE, CY, PL, UK 5 7.1
At holding level AT, BE, CY, DE, EL, FI, HR, HU, IE, IS, IT, LT, LU, MT, NL, NO, PL, SK, UK 19 67.9
At community level through the same services used by the general
population
AT, BE, BG, CY, DE, DK, EE, EL, ES, FI, FR, HR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO, PT,
SE, SI, UK
26 92.9
At community level, through health services dedicated to migrants DE, EL, FI, IE, NO, PL, UK 7 25.0
Informed consent before vaccinating
Not requested EE 1 3.6
Written consent AT, IE, IT, LT, LU, PL, SK 7 25.0
Verbal consent BE, BG, CY, DK, EL, ES, FI, FR, HR, HU, IS, LV, MT, NL, NO, PT, SE, SI, UK 19 67.9
Written or verbal consent depending on the locality DE 1 3.6
Payment
Vaccinations offered free of charge AT, BE, BG, CY, DE, DK, EL, ES, FI, FR, HR, HU, IS, IT, LT, LU, LV, MT, NL, PL, PT, SK, UK 21 75.0
Migrants have to pay for some of the vaccinations EE, IE, IS, NO, PL, SE, SI 7 25.0
IE: a ‘‘catch up” schedule is available for adult migrants with unknown vaccination status: BCG vaccine is offered to migrants up to 35 years of age if belonging to high risk
groups; Men C vaccine for those up to 23 years of age; MMR vaccine 2 doses, delivered 1 month apart; Tdap/IPV vaccine one dose followed by two doses of dT/IPV vaccine at
one month interval.
MT: one dose of IPV, diphtheria and tetanus vaccines.
IE: vaccines are offered free of charge (both vaccine and administration) to refugees and asylum seekers. For irregular migrants, access to free vaccines is available, but costs
for administration may be applied (unless provided by NGO service).
IS: adult migrants get free vaccination if they have not received vaccination according to our national schedule. Other vaccinations are not free of charge.
NO: MMR and IPV are offered free of charge to all migrants and BCG depending on defined risk groups. All the other vaccines are not free of charge.
PL: adult migrants receive only certain vaccines free of charge (MMR, IPV, HepB, BCG, DT), instead all vaccines included in the NIP are free for children and adolescents,
according to law.
SE: some vaccinations are offered free-of-charge if there is an epidemiological indication or in case of specific risk conditions or in some Regions.
SI: vaccinations are offered free-of-charge if there is an epidemiological or clinical indication or in case of specific risk conditions.
# FR: national guidelines for vaccination of persons with unknown or uncertain status (including migrants) are expected in 2019.
## ES: hepatitis B, varicella; IE: hepatitis B status for migrants coming from endemic regions; IT: hepatitis B and tetanus; SK: hepatitis B.
* FI: a special scheme exists only for asylum seekers with uncertain immunization status (they are offered a booster dose of dT, IPV and MMR vaccines); resident migrants
are offered vaccinations according to the NIP.
 FR: vaccinations are free of charge for most of the migrants as the French citizens, with modalities of reimbursement depending on administrative status (French citizen and
regular migrants: 65% covered by the national health insurance, and 35% by private complementary insurance or complementary state insurance according to the incomes –
undocumented migrants: 100% covered by the state medical assistance for mandatory vaccinations). Additionally, vaccination can be performed free of charge in public
vaccination clinics.
 EE: adult migrants have to pay the following vaccines: MMR, HepB, polio.
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WHO-UNHCR-UNICEF principles [18] of recommending that access
to vaccination should be provided as part of the overall health sup-
port offered to migrants. According to survey respondents, 28 out
of 29 participating countries have implemented immunisation
policies targeting migrants. However, policies and practices differ
significantly across the EU, as has already been reported in the lit-
erature [25–27].
4.1. Policies and practices
The results from the survey showed that in the case of children/
adolescent migrants, almost all (27) of the 28 countries having
strategies for migrant immunization offer all vaccinations included
in the NIP, in line with the international recommendations
[21,23,24].
Reportedly, there are different immunisation policies in place
for adult migrants across EU/EEA countries with 13/28 countries
offering all vaccinations included in the NIP appropriate for age,
whereas the remaining countries offer only certain vaccinations,
mostly IPV, MMR, diphtheria and tetanus vaccines, as outlined in
the ECDC guidance on screening and vaccination for infectious dis-
eases in newly arrived migrants within the EU/EEA [24].Additionally, in seven countries the vaccinations offered are not
provided to all adult migrants, but limited to those migrants with
specific conditions (such as specific health condition or country of
origin). We expected this heterogeneity given that in EU countries
immunisation programmes targeting adults are generally less well
consolidated when compared to childhood immunisation pro-
grammes, even when targeting the general populations [28].
A survey that was conducted in 2017 by the European Society
for Clinical Microbiology and Infectious Diseases (ESCMID) that
explored approaches to vaccination in recently arrived migrants
in 31 EU/EEA countries [27], showed considerable variations in
approaches between children and adults. In line with our study,
the authors found that children mostly enter the national vaccina-
tion schedule of the host country, whereas the results of the survey
differed in regards to the immunisations offered to adults. In fact,
according to the ESCMID findings, adult migrants seem to be
excluded from catch-up vaccination initiatives in most countries:
priority was given to DTP, polio and MMR vaccine (in line with
our results), however around half of the countries reported offering
these vaccinations to adults. Instead, as mentioned above, we
found that 28 reporting countries have immunisation policies
targeting adult migrants, although seven of them limit the offer
to those with certain conditions. To explain this difference,
Table 6
Information on vaccines delivered to migrants: data collection (N = 28).
Countries n %
How is information on delivered vaccines recorded?
Children/adolescent migrants
Individual vaccination cards delivered to migrants AT, BE, BG, CY, DE, DK, EE, EL, FR, HR, HU, IE, IS, IT, LT, LU, LV, NL, NO, PT,
SI, SK, UK*
23 82.1
Electronic database specifically for migrants’ immunisation DE, DK, FI, HR, LU, PL 6 21.4
Paper archives specifically for migrants’ immunisation EL, HU, LU 3 10.7
Electronic immunisation registries for the general populations BE, ES, FI, IE**, IS, IT, MT, NL, NO, PT, SE, UK 12 42.9
Paper immunisation registries for the general population BG, HU, IT, LV, SK 5 17.9
Other CY***, IE**, UK* 3 10.7
Adult migrants
Individual vaccination cards delivered to migrants AT, BE, BG, CY, DE, DK, EE, EL, FR, HR, HU, IE, IS, IT, LT, LU, LV, MT, NL, NO,
PT, SI, SK, UK*
24 85.7
Electronic database specifically for migrants’ immunisation DE, DK^, FI, HR, LU, PL 6 21.4
Paper archives specifically for migrants’ immunisation HU, LU 2 7.1
Electronic immunisation registries for the general populations BE, ES, FI, IS, IT, NL, NO, PT, UK 9 32.1
Paper immunisation registries for the general population BG, HU, IT, LV, SK 5 17.9
Other CY***, SE^^, UK* 3 10.7
Are any data on migrant’s compliance to vaccination or immunisation
coverage collected?
No AT, BE, BG, CY, DK, EE, EL, ES, FR, HR, HU, IS, LT, LV, MT, NO, PT, SE, SI, UK 20 71.4
Yes, data available at national level NL, PL, LU 3 10.7
Yes, data collected only in some localities DE, IE, IT 3 10.7
Other FI 1 3.6
I don’t know SK 1 3.6
* UK: refugees entering the UK through the re-settlement programme have their information (full pre-entry medical health assessment, including vaccination) stored on a
specific electronic database, which can be accessed by the relevant health services.
** IE: for children < 2 years of age, data are entered into local immunisation database as for resident population. For older children records are kept on file in holding centres
and sent to the GP who takes on care when person moves.
*** CY: is about to establish an electronic database in collaboration with UN services and NGOs.
^ DK: the asylum system has their own health record which follows the migrants and cannot use the public electronic vaccination register because they do not have
personal identifier; when asylum status is obtained, data may be entered in the National Vaccination Register.
^^ SE: the information is recorded in individual medical record; in some regions it is recorded in electronic immunization registries.
 FI: preliminary data on MMR and influenza vaccination coverage among second generation migrant children is available.
Table 7
Information on vaccines delivered to migrants: data sharing with other centres/institutions (N = 28).
Countries n %
Are individual/aggregated data made available and transmitted from the sites where vaccinations are delivered to other centres or institutions?
Individual data
No AT, EE, EL, FR, HU, LT, LU, LV, MT, PL, PT, SE, SI 13 46.4
To centres where migrants are relocated or moved BE, CY, DK, FI, IE, NO, SK 7 25.0
To the Ministry of Health – –
To the National Public Health Institute HR, NL, UK* 3 10.7
To the Regional Health Authorities ES 1 3.6
To the Local Health Authorities FI, IT, UK* 3 10.7
To the national/regional Epidemiology Centres HR, IS 2 7.1
To international institution (ECDC, IOM, WHO, UNHCR) UK (IOM)* 1 3.6
Information not available at the national level BG, IT 2 7.1
Other BE^, DE^^, DK^^, 3 10.7
Aggregated data
No AT, DE, DK, FR, IE, IS, LU, LV, MT, NO, PT, SE, SI, SK, UK 15 53.6
To the Ministry of Health BG, CY, EL, ES 4 14.3
To the National Public Health Institute BE, EE, FI, HR, NL 5 17.9
To the Regional Health Authorities BE, BG, DE, EE, LT 5 17.9
To the Local Health Authorities EE, HU, IT 3 10.7
To the national/regional Epidemiology Centres PL 1 3.6
To the national/regional Migrant Health Centres FI 1 3.6
To international institution (ECDC, IOM, WHO, UNHCR) –
^^^DK: the asylum system has their own health record which follows the migrant and cannot use the public electronic vaccination register because they don’t have personal
identifier; when asylum status is obtained, data may be entered in the National Vaccination Register, but it is not possible to see if it is a migrant being vaccinated.
* UK: refugees entering the UK through the re-settlement programme have their information (full pre-entry medical health assessment, including vaccination) stored on a
specific electronic database, which can be accessed by the relevant health services. The information is shared with the: (i) International Organization for Migration, (ii) the
Home Office Refugee resettlement programme and (iii) Public Health England, (iv) Local Authorities, (v) health services e.g. GP.
^ BE: through the electronic registration system to specific health personnel involved in vaccination.
^^ DE: individual data can be entered into a central database for migrants, which can be accessed by the federal institute for migration and public health authorities
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Table 8
Procedures for migrants’ access to vaccinations (N = 28).
Countries n %
How is migrants’ access to vaccinations at the community level guaranteed when vaccinations are not previously delivered at borders or at holding levels?
No specific procedure BG, CY, DK, ES, HU, IE, IT*, LT, LV, SI, SK, UK 12 42.9
Migrants are informed of their vaccination needs but
they access to vaccinations at the community
level by themselves
AT, DE*, DK, EL, FR*, IT*, PL, PT, SE 9 32.1
Migrants are informed of their vaccination needs and
dedicated health/social staff facilitate their access
to vaccinations at the community level
BE, EE, FI, FR*, HR, IS, IT*, LU, MT, NL, NO, PT 12 42.9
A systematic flow of information from borders/
holding centres and vaccination services in the
community is established
BE, IT*, NL, UK** 4 14.3
Formal agreement between centres and private/
public health services are signed to facilitate
migrants’ access to vaccinations at the
community level
BE, FR*, IE, IT* 4 14.3
Practical experiences related to migrants’ access to vaccination
BE Migrants are mainly vaccinated at entry level and in reception centres. Once the migrants leave the reception
centre, children and adults are vaccinated at the local health services. For children < 6 years of age, information
on vaccination status of the children is transmitted to the paediatric services that continue at community level
the immunisation programme started at the reception centres. For individuals aged 6–18 years, information is
transmitted to school health services. For adults, most of the vaccination is completed at entry level and in the
reception centres. If not, people are vaccinated by the GP or other medical staff, who can look for the
information on previous vaccinations in the electronic immunisation registry for the general population.
FI After arrival, all refugees and asylum seekers are offered a nurse appointment and an initial health examination
where the vaccination status is checked and necessary vaccinations are recommended. Some vaccines might
already be given at the first appointment. Nurses facilitate the migrants’ access to subsequent vaccinations by
booking new appointments.
HR Physicians working in the asylum centres cooperate with the local epidemiology unit to guarantee migrants
immunisation. Upon arrival in the holding centre, an initial health examination is performed and the
vaccination status is checked. If vaccinations are recommended, the local epidemiology unit provides needed
vaccines.
LU If other vaccinations than those proposed according to the NIP are needed, migrants receive a prescription from
the GP appointed by the Health Ministry, visiting on a regular basis the holding centres, to organise the
requested vaccination in collaboration with an independent GP. This procedure is due to the fact that the GP
appointed by the Ministry of Health is not entitled to vaccinate people. Therefore, an independent GP, practicing
in a private practice, is involved. The independent GP is paid on a fee, with the cost of this service covered by the
national health system (free-of-charge for the migrant). The appointments with the independent GP is taken in
collaboration with the social workers.
MT Migrants are given appointments for vaccination at the immunisation centre.
NO All migrants are offered a medical examination at community level and information about vaccination is part of
this.
SK Migrants in the asylum centre are visited by the health care professionals authorised by the Ministry of Interior
Affairs; they perform the medical check-up and might direct certain people to other necessary medical
procedures and for certain vaccinations.
UK There is not a specific procedure but all refugees who are resettled through a resettlement scheme undergo a
pre-departure health assessment in the country of origin, where they are offered vaccination/catch-up
vaccination in line with the NIP.
* DE, FR, IT: Procedures vary locally.
** UK: there is no specific procedure but at the time of registration with a GP a health check is con ducted and this includes checking immunisation status (and offering
catch-up vaccinations). For refugees only, a systematic flow of information from borders/holding centres and vaccination services in the community is established.
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ent stakeholders.
The WHO-UNHCR-UNICEF guidance [21] states that refugees
and asylum seekers should have non-discriminatory and equitable
access to health care services, including vaccines, irrespective of
their legal status. In our survey all countries offer vaccination to
asylum seekers, both children/adolescents and adults; however,
the immunisation offer is less frequently extended to irregular
migrants, especially adult. This leaves the potential for a significant
number of unimmunised migrants. Estimating the number of
irregular migrants is, by definition, problematic since we are deal-
ing with a phenomenon that is outside the control of states; the
European project Clandestino estimated the size of the irregular
migrant population in Europe at 1.9 million to 3.8 million in
2009 [29].
The administration of the full vaccination schedule, which may
require multiple appointments (with intervals of months among
the doses), poses additional challenges when dealing with mobilepopulations such as migrants. We found that vaccinations are
mainly delivered at holding and community level, in line with
international indications that recommend not to vaccinate at bor-
der crossings unless there is an outbreak of a VPD in the host or
transit country [21]. Starting immunisation at holding or commu-
nity level makes planning and completion of the vaccination cycle
and recording of information more feasible. The community-based
service was identified as the main delivery model also among the
EU and non-EU countries of the Mediterranean Area and the Black
Sea basin [30].
Assessment of immunisation status before vaccinating is possi-
ble for certain diseases using serology, however this practice is
uncommon and costly. In our study, very few countries take into
consideration laboratory testing in case of unknown immunisation
status. Previous ECDC guidance suggested verifying immunisation
status for all migrants using available documentation and, if no or
uncertain documentation exists, the individual should be consid-
ered unvaccinated [23,24]. A systematic review conducted in
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vaccination serological testing [31]. Moreover, it is often unreliable
and could represent an unnecessary delay for a population which
may be lost to follow-up.
4.2. Critical issues and next steps needed
We identified several critical issues. Firstly, information on deliv-
ered vaccines tomigrants is not routinely entered into immunisation
registries in several countries. To our knowledge, this is the first sur-
vey exploring the systems in place for the recording and sharing of
data on immunised migrants in EU/EEA countries. Data collection
methods are very heterogeneous (paper or electronic registries;
databases specific for migrants or for general population), making
it difficult to exchange and share information across countries.
Immunisation data are transmitted to centres where migrants are
relocated in only seven countries and to international institutions
in only one country. To plan or complete a vaccination course, it is
essential to keep track of delivered vaccines. The WHO-UNHCR-
UNICEF guidance states that each vaccinee or child’s caregiver
should be provided with documentation of the vaccinations given
to help avoid duplication of vaccination [21]. We found that in the
majority of EU/EEA countries a vaccination card is delivered to
migrants after immunisation, however this is considered insufficient
to adequately track vaccinations administered to migrants because it
can be lost during the journey or destroyed for the purpose of hin-
dering personal identification. Since immunisation is a health inter-
vention requiring a continuum of follow-up until the full schedule is
complete, and migrants are subject to movement within and across
countries, there is a need to consider stronger cooperation between
the countries of arrival, transit and destination to develop better doc-
umentation and promote its sharing across countries. This would
help to avoid migrants being left unprotected or being administered
with unnecessary doses of vaccine.
Secondly, although immunisation is offered to migrants, their
utilisation of services providing vaccinations could be limited. In
our study, standard procedures to ensure migrants’ access to vac-
cination at the community level (dedicated staff, systematic flow
of information or formal agreement between centres and immuni-
sation/health services) are in place in half of the surveyed coun-
tries. It is documented that several factors influence migrants’
utilization of immunisation services, such as limited or no entitle-
ment to health services, socio-cultural, educational-related, and
socioeconomic reasons [32–34]. Also low income could create dif-
ficulties in accessing services that require any payment, even if the
payment is minimal [32]. We found that certain vaccinations are
not free-of-charge for all adolescent and/or adult migrants in seven
countries. A 2017 study compared access to preventive health ser-
vices between migrants and the general population in five EU
countries and found that migrants have poorer access to Pap smear
tests, colorectal cancer screening and influenza vaccination than
the general population [35]. Differences also exist among migrant
groups, with refugees reported to have a lower uptake of services
compared with asylum seekers, and undocumented migrants are
often excluded from national health services [29]. The European
Vaccine Action Plan 2015–2020 proposes that all Member States
in the Region pay special attention to migrants, international trav-
ellers and marginalised communities to ensure their eligibility and
access to culturally competent immunisation services and infor-
mation [36] and the UCL-Lancet Commission on Migration and
Health proposes that solutions should include input from migrants
and be specific to the diverse migrant populations [37].
We have collected some practical experiences related to
migrants’ access to vaccination (Table 8), whose sharing across
countries could be useful to create models for ensuring migrant
immunisation uptake and overcoming the barriers mentionedabove. However, it should be underlined that the effectiveness of
those procedures has not as yet been evaluated. A more compre-
hensive collection of good practices and experiences is being car-
ried out by the WHO Regional Office for Europe, contributing to
the development of an Action Plan to promote the health of refu-
gees and migrants to be considered at the Seventy-second World
Health Assembly [38].
Thirdly, we found that only three countries have national data
on migrants’ immunisation coverage. The collection of coverage
data represents a pre-requisite for effective evaluation of interven-
tions, which might highlight the need of corrective measures.
Long-term strategies on migrant immunisation, other than indica-
tions for vaccination of target groups, setting and modalities of
delivery, should also include procedures for data collection and
evaluation as necessary phases of the whole process.4.3. Strengths and limits
The strength of our survey is that the questionnaire was com-
pleted by experts belonging to an established longstanding ECDC net-
work (or experts officially identified by the components of this
network), involving country representatives working permanently
within the area of VPDs at national level. Moreover, our survey was
conducted in the frame of the VENICE project, working in the field
of VPDs for over 12 years (http://venice.cineca.org/the_project.html).
The main limitation of our study is that we explored policies and
practices at the national level but did not access their local imple-
mentation. In the framework of the 2017 ESCMID survey [27], EU/
EEA country experts were asked if policies/guidelines for migrant
vaccination are applied in practice with migrants: four of 32 experts
stated they were always applied in practice, 16 only partly and two
reported they were never applied in practice. Although that is an
expert opinion, it shows that the development of a national policy
does not always translate into its practical implementation. A review
exploring the provision of immunisation services to migrants and
refugees identified three main factors from the literature as being
responsible for a lack of implementation of national recommenda-
tions and policies at the local level: staff shortage, poor training for
health care providers on migrants’ health needs and a lack of routine
data collection and evaluation [32].
Another limitation of our survey is that, although at the top of
the questionnaire we clearly suggested experts to refer to the
IOMmigration-related definitions [1], some respondents may have
interpreted the term migrant somewhat differently. In addition, in
some countries, the entitlement to health services depends on
immigration status: immunisation policies and practices might dif-
fer between refugees, asylum seekers and irregular migrants, thus
making it difficult to answer those questions regarding ‘‘all
migrants” as per IOM Glossary.
Before concluding, we would like to cite the EU Council Recom-
mendation for strengthening cooperation among EU countries in
the fight against VPDs, adopted in December 2018 [20,39]. Among
the recommendations, the European Commission recommends the
development a virtual repository EU data warehouse with informa-
tion on vaccine stocks and needs to mitigate the risks of shortages,
mentioning, among the possible causes of shortage, extraordinary
events such as an influx of migrants. We found that none of the
responding countries have experienced vaccine shortage in the
past two years due to provision of vaccinations to migrants.5. Conclusion
According to our respondents, international recommendations
on migrant immunisation [21] have been adopted in 28 out of 29
EU/EEA countries who participated in the survey, although offered
5450 C. Giambi et al. / Vaccine 37 (2019) 5439–5451vaccinations, target groups, settings and modalities of delivery
vary between countries, especially for adult migrants. Information
on immunised migrants are collected, recorded and shared with
other centres/institutions in a very limited number of countries,
and with highly heterogeneous methods.
Further work might be needed to reduce the impact of different
vaccination policies targeting migrants in different countries. How-
ever, this may be difficult to do due to varied migration patterns,
financial resources and diverse health systems organisation.
Also, efforts could potentially be focused on strengthening part-
nerships and implementing initiatives across countries of arrival,
transit and destination to develop and share better documentation
in order to ensure immunisation and avoid revaccination. A
common vaccination card that can be shared electronically across
borders, as proposed by the European Commission in 2018, could
be a successful method [20,39].
Finally, although vaccination is offered to migrants in most
EU/EEA countries, migrants’ utilisation of health services that
provide vaccinations is not always ensured due to linguistic,
socio-cultural and economic barriers. Development of migrant-
friendly strategies to increase access to vaccinations at the commu-
nity level, such as dedicated staff, systematic flow of information or
formal agreement between centres and immunisation/health
services, should be encouraged. Also targeted interventions, for
example door to-door vaccination initiatives, media campaigns
and health promotion interventions, should be promoted to
improve migrant vaccination uptake, in line with national guideli-
nes and recommendations. More research is needed to identify
cost-effective and acceptable interventions [31,40] and, in general,
better information and disaggregated data to support decision-
makers to develop evidence-based policies, plans and intervention
as stated in the WHO draft Global Action Plan 2019–2023 on pro-
moting the health of refugees and migrants [41].6. Authors’ contributions
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